The Korean Journal of Gastroenterology (대한소화기학회지)

The Korean Society of Gastroenterology (대한소화기학회)
권호 표지
DOI QR코드

DOI QR Code

Current Issues on Gastroesophageal Reflux Disease

위식도역류질환의 최근 동향

  • Published : 2014.09.25
⟨ Previous Next ⟩

Abstract

Gastroesophageal reflux disease (GERD) is one of the most common problems in gastrointestinal disorders. With the increase in our understanding on the pathophysiology of GERD along with the development of proton pump inhibitors, the diagnostic and therapeutic approaches to GERD have changed dramatically over the past decade. However, GERD still poses a problem to many clinicians since the spectrum of the disease has evolved to encompass more challenging presentations such as refractory GERD and extraesophageal manifestations. This has led to significant confusion regarding the optimal approach to these patients. This article aims to discuss current issues on GERD.

Keywords

References

  1. Beaumont H, Bennink RJ, de Jong J, Boeckxstaens GE. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD. Gut 2010;59:441-451. https://doi.org/10.1136/gut.2009.178061
  2. Fletcher J, Wirz A, Young J, Vallance R, McColl KE. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology 2001;121:775-783. https://doi.org/10.1053/gast.2001.27997
  3. Boeckxstaens GE, Rohof WO. Pathophysiology of gastroesophageal reflux disease. Gastroenterol Clin North Am 2014;43:15-25. https://doi.org/10.1016/j.gtc.2013.11.001
  4. Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004;53:1024-1031. https://doi.org/10.1136/gut.2003.033290
  5. Jung HK, Hong SJ, Jo YJ, et al; Korean Society of Neurogastroenterology and Motility. Updated guidelines 2012 for gastroesophageal reflux disease. Korean J Gastroenterol 2012;60:195-218. https://doi.org/10.4166/kjg.2012.60.4.195
  6. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2013;108:308-328. https://doi.org/10.1038/ajg.2012.444
  7. Hirano I, Richter JE; Practice Parameters Committee of the American College of Gastroenterology. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol 2007;102:668-685. https://doi.org/10.1111/j.1572-0241.2006.00936.x
  8. Cool M, Poelmans J, Feenstra L, Tack J. Characteristics and clinical relevance of proximal esophageal pH monitoring. Am J Gastroenterol 2004;99:2317-2323. https://doi.org/10.1111/j.1572-0241.2004.40626.x
  9. Gyawali CP. High resolution manometry: the Ray Clouse legacy. Neurogastroenterol Motil 2012;24(Suppl 1):2-4.
  10. Mello M, Gyawali CP. Esophageal manometry in gastroesophageal reflux disease. Gastroenterol Clin North Am 2014;43:69-87. https://doi.org/10.1016/j.gtc.2013.11.005
  11. Frankhuisen R, Van Herwaarden MA, Scheffer RCh, Hebbard GS, Gooszen HG, Samsom M. Increased intragastric pressure gradients are involved in the occurrence of acid reflux in gastroesophageal reflux disease. Scand J Gastroenterol 2009;44:545-550. https://doi.org/10.1080/00365520902718903
  12. Khajanchee YS, Cassera MA, Swanstrom LL, Dunst CM. Diagnosis of Type-I hiatal hernia: a comparison of high-resolution manometry and endoscopy. Dis Esophagus 2013;26:1-6. https://doi.org/10.1111/j.1442-2050.2011.01314.x
  13. Chan WW, Haroian LR, Gyawali CP. Value of preoperative esophageal function studies before laparoscopic antireflux surgery. Surg Endosc 2011;25:2943-2949. https://doi.org/10.1007/s00464-011-1646-9
  14. Jobe BA, Richter JE, Hoppo T, et al. Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel. J Am Coll Surg 2013;217:586-597. https://doi.org/10.1016/j.jamcollsurg.2013.05.023
  15. Ghosh SK, Pandolfino JE, Kwiatek MA, Kahrilas PJ. Oesophageal peristaltic transition zone defects: real but few and far between. Neurogastroenterol Motil 2008;20:1283-1290. https://doi.org/10.1111/j.1365-2982.2008.01169.x
  16. Kumar N, Porter RF, Chanin JM, Gyawali CP. Analysis of intersegmental trough and proximal latency of smooth muscle contraction using high-resolution esophageal manometry. J Clin Gastroenterol 2012;46:375-381. https://doi.org/10.1097/MCG.0b013e31823d3403
  17. Armstrong D, Marshall JK, Chiba N, et al; Canadian Association of Gastroenterology GERD Consensus Group. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults: update 2004. Can J Gastroenterol 2005;19:15-35. https://doi.org/10.1155/2005/836030
  18. Kahrilas PJ, Shaheen NJ, Vaezi MF, et al; American Gastroenterological Association. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology 2008;135:1383-1391.e5. https://doi.org/10.1053/j.gastro.2008.08.045
  19. Fock KM, Talley NJ, Fass R, et al. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol 2008;23:8-22.
  20. Shaheen NJ, Weinberg DS, Denberg TD, Chou R, Qaseem A, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med 2012;157:808-816. https://doi.org/10.7326/0003-4819-157-11-201212040-00008
  21. Sharma P, Shaheen NJ, Perez MC, et al. Clinical trials: healing of erosive oesophagitis with dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed-release formulation-- results from two randomized controlled studies. Aliment Pharmacol Ther 2009;29:731-741. https://doi.org/10.1111/j.1365-2036.2009.03933.x
  22. Fass R, Murthy U, Hayden CW, et al. Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy-a prospective, randomized, multi-centre study. Aliment Pharmacol Ther 2000;14:1595-1603. https://doi.org/10.1046/j.1365-2036.2000.00882.x
  23. Zerbib F, Roman S, Ropert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 2006;101:1956-1963. https://doi.org/10.1111/j.1572-0241.2006.00711.x
  24. Zhang Q, Lehmann A, Rigda R, Dent J, Holloway RH. Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 2002;50:19-24. https://doi.org/10.1136/gut.50.1.19
  25. Rohof WO, Lei A, Hirsch DP, et al. The effects of a novel metabotropic glutamate receptor 5 antagonist (AZD2066) on transient lower oesophageal sphincter relaxations and reflux episodes in healthy volunteers. Aliment Pharmacol Ther 2012;35:1231-1242. https://doi.org/10.1111/j.1365-2036.2012.05081.x
  26. Hershcovici T, Fass R. Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy. Drugs 2011;71:2381-2389. https://doi.org/10.2165/11597300-000000000-00000
  27. Vela MF, Craft BM, Sharma N, Freeman J, Hazen-Martin D. Refractory heartburn: comparison of intercellular space diameter in documented GERD vs. functional heartburn. Am J Gastroenterol 2011;106:844-850. https://doi.org/10.1038/ajg.2010.476
  28. Yoshida N, Kamada K, Tomatsuri N, et al. Management of recurrence of symptoms of gastroesophageal reflux disease: synergistic effect of rebamipide with 15 mg lansoprazole. Dig Dis Sci 2010;55:3393-3398. https://doi.org/10.1007/s10620-010-1166-9
  29. Adachi K, Furuta K, Miwa H, et al. A study on the efficacy of rebamipide for patients with proton pump inhibitor-refractory non-erosive reflux disease. Dig Dis Sci 2012;57:1609-1617. https://doi.org/10.1007/s10620-012-2087-6
  30. Viazis N, Keyoglou A, Kanellopoulos AK, et al. Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study. Am J Gastroenterol 2012;107:1662-1667. https://doi.org/10.1038/ajg.2011.179
  31. Dickman R, Schiff E, Holland A, et al. Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn. Aliment Pharmacol Ther 2007;26:1333-1344. https://doi.org/10.1111/j.1365-2036.2007.03520.x
  32. Jones H, Cooper P, Miller V, Brooks N, Whorwell PJ. Treatment of non-cardiac chest pain: a controlled trial of hypnotherapy. Gut 2006;55:1403-1408. https://doi.org/10.1136/gut.2005.086694
  33. Rohof WO, Bennink RJ, de Ruigh AA, Hirsch DP, Zwinderman AH, Boeckxstaens GE. Effect of azithromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period. Gut 2012;61:1670-1677. https://doi.org/10.1136/gutjnl-2011-300926
  34. Rohof WO, Bennink RJ, Smout AJ, Thomas E, Boeckxstaens GE. An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2013;11:1585-1591. https://doi.org/10.1016/j.cgh.2013.04.046
  35. Kim D, Velanovich V. Surgical treatment of GERD: where have we been and where are we going? Gastroenterol Clin North Am 2014;43:135-145. https://doi.org/10.1016/j.gtc.2013.12.002
  36. Rodriguez L, Rodriguez P, Gomez B, et al. Long-term results of electrical stimulation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease. Endoscopy 2013;45: 595-604. https://doi.org/10.1055/s-0033-1344213

Cited by

  1. 이진탕가미방(二陳湯加味方)을 투여한 불응성 위식도역류질환의 증례군 연구 vol.38, pp.6, 2014, https://doi.org/10.22246/jikm.2017.38.6.1085
  2. 역류성 식도염 생쥐 모델에서 해표초, 와릉자, 모려와 Esomeprazole의 치료효과에 대한 비교 연구 vol.39, pp.2, 2018, https://doi.org/10.13048/jkm.18018
  3. Development of Physiologically Based Pharmacokinetic Model for Orally Administered Fexuprazan in Humans vol.13, pp.6, 2014, https://doi.org/10.3390/pharmaceutics13060813